8 Best Small-Cap Growth Stocks to Buy According to Analysts
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
Posts Tagged ‘NASDAQ:CLDX’
10 Most Promising Small-Cap Stocks According to Hedge Funds
Small-cap stocks are offering a myriad of opportunities to investors and are expected to go higher.
10 Worst Cancer Stocks To Buy Now According to Short Sellers
Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one of the largest sectors in the life sciences.
5 Best Immunology Stocks to Invest In
In this article, we discuss the 5 best immunology stocks to invest in.
Top 10 Biotech Stocks to Buy According to Jeremy Green’s Redmile Group
In this article, we will discuss the top 10 biotech stocks to buy according to Jeremy Green's Redmile Group.
Hedge Funds Are Crazy About Celldex Therapeutics, Inc. (CLDX)
In this article we are going to use hedge fund sentiment as a tool and determine whether Celldex Therapeutics, Inc. (NASDAQ:CLDX) is a good investment right now.
Should I Avoid Celldex Therapeutics, Inc. (CLDX)?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
5 Stocks to Buy According to Neil Shahrestani’s Ikarian Capital
In this article, we will discuss the 10 stocks to buy according to Neil Shahrestani's Ikarian Capital.
Where Do Hedge Funds Stand On Celldex Therapeutics, Inc. (CLDX)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Is CLDX Stock A Buy or Sell?
In this article we will take a look at whether hedge funds think Celldex Therapeutics, Inc. (NASDAQ:CLDX) is a good investment right now.
Hedge Funds Have Never Been This Bullish On Celldex Therapeutics, Inc. (CLDX)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Hedge Funds Are Dumping Celldex Therapeutics, Inc. (CLDX)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Is Celldex Therapeutics, Inc. (CLDX) A Good Stock To Buy?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Fund and Insider Trading News: King Street Capital, Third Point LLC, Alta Mesa Resources Inc (AMR), HubSpot Inc (HUBS), MYnd Analytics Inc (MYND), and More
TOKYO—New York-based hedge fund King Street Capital Management LP has proposed new independent directors at Toshiba Corp., according to people familiar with the matter, the ...
Is Celldex Therapeutics, Inc. (CLDX) a Good Stock To Buy?
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
Three Cancer Plays For The Fourth Quarter Of 2016
We are now into the final quarter of 2016, and there looks set to be plenty of activity across the biotech space before the year draws to a close.
Here’s Why These Five Stocks Are Gaining Ground Today
In spite of better-than-expected April retail sales data, U.S.
Hedge Funds Wisely Fled These Tanking Stocks
The importance of hedge fund sentiment is not only reflected by the long positions that these firms take in high flying companies, but also how quickly are they able to back out...
Here is What Hedge Funds Think About Celldex Therapeutics, Inc. (CLDX)
Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say...
Dendreon Corporation (DNDN), Celldex Therapeutics, Inc. (CLDX): Is There Still Upside in Immunotherapy?
Three years ago, cancer immunotherapy was the hottest thing in biotech, as Dendreon Corporation (NASDAQ:DNDN)'s Provenge earned approval from the Food and Drug Administration ...
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Celldex Therapeutics, Inc. (CLDX), Dendreon Corporation (DNDN): Why Wall Street Has Turned Against It
Since Dendreon Corporation (NASDAQ:DNDN) reported its second-quarter earnings, the stock has declined 40%.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we've seen from the smart money, out of the entire stock market universe and the 500+ elite...
Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): This Company Has Potential to Grow
Cancer is the target of a number of different biotech companies. Out of this lot, I consider Seattle Genetics, Inc. (NASDAQ:SGEN) to be one of the star performers.
Keryx Biopharmaceuticals (KERX): Rare Diseases and Rare Drugs Could Mean Great Gains For You
The U.S. is the largest market of biotechnology products in the world.
Celldex Therapeutics, Inc. (CLDX): 4 Reasons This Biotech Went up by 400 Percent
Celldex Therapeutics, Inc. (NASDAQ:CLDX), the first antibody-based immunotherapy company, has been a strong buy recommended by several analysts for some time now.
ACADIA Pharmaceuticals Inc. (ACAD), Alnylam Pharmaceuticals, Inc. (ALNY) & Celldex Therapeutics, Inc. (CLDX): Buy These Biotech Companies for Long-Term Growth
According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year.
Alnylam Pharmaceuticals, Inc. (ALNY)’s Surge Caps Off a Strong Week in Biotech
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry.
Onyx Pharmaceuticals, Inc. (ONXX), Celldex Therapeutics, Inc. (CLDX): Three Humongous Health-Care Stocks This Week
While many American skies were lit up with fireworks this week, the stock market also saw its share of pops, sizzles, and bangs.
Celldex Therapeutics, Inc. (CLDX) On The Rise
There are many biotech stocks that target cancer, but what is good about Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. (CLDX), ACADIA Pharmaceuticals Inc. (ACAD): Two Biotech Stocks That Could Soon be Acquired
The final catalyst is the one that I am reviewing today. I am looking at two companies that look to be attractive acquisition targets.
Celldex Therapeutics, Inc. (CLDX), Galena Biopharma Inc (GALE): Good And Bad Breast Cancer Drugs
With more than 230,000 women diagnosed with breast cancer in the U.S.
ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics, Inc. (CLDX): A Trio of Cancer Immunotherapy Innovators
The cancer world has been abuzz after an exciting ASCO conference. Bristol Myers Squibb Co.
MannKind Corporation (MNKD): Are Hedge Funds Right About This Stock?
According to most stock holders, hedge funds are viewed as underperforming, old financial vehicles of the past.
Dendreon Corporation (DNDN), Celldex Therapeutics, Inc. (CLDX): A Promising Platform for Cancer Immunotherapy
A 2011 Nobel Prize in Physiology and Medicine is certainly impressive. Using a novel cancer treatment on yourself is both impressive and courageous. Dr.
Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)
In the eyes of most traders, hedge funds are seen as worthless, old financial tools of the past.
Do Hedge Funds and Insiders Love Celldex Therapeutics, Inc. (CLDX)?
In the financial world, there are plenty of indicators market participants can use to track publicly traded companies.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds and Insiders Are Bearish, What Should You Do?
If you'd ask most shareholders, hedge funds are assumed to be slow, outdated investment tools of the past.
Ariad Pharmaceuticals, Inc. (ARIA) Among The Biotech Players To Watch
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is on the focused approach trajectory, using its solid foundation in the sciences to fill the holes left open by big pharma. Celldex...
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds' portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge fund interest of late.
Puma Biotechnology Inc (PBYI), Achillion Pharmaceuticals, Inc. (ACHN): Here is What Hedge Funds Think About NPS Pharmaceuticals, Inc. (NPSP)
According to most investors, hedge funds are perceived as worthless, old financial tools of years past.
Celldex Therapeutics, Inc. (NASDAQ:CLDX): Insiders Are Dumping, Should You?
Is Celldex Therapeutics, Inc. (NASDAQ:CLDX) ready to raly soon? Money managers are selling.
AstraZeneca plc (ADR) (AZN), Pfizer Inc. (PFE): Celldex Therapeutics, Inc. (CLDX) Is Still a Buy
There has been a significant rally in the share price of Celldex Therapeutics, Inc. (NASDAQ:CLDX) recently.
3 Humongous Health-Care Stocks This Week: Celgene Corporation (CELG), Celldex Therapeutics, Inc. (CLDX)
The Dow set an all-time high, but it still was up only 2% for the week. If you want returns to really get excited about, look no further than the health-care sector.
5 of Last Week’s Biggest Winners: Radian Group Inc. (RDN), Magnum Hunter Resources Corp (MHR) and More
YY spiked after Citi and Morgan Stanley initiated coverage of the Chinese online gaming and communications speedster with bullish ratings.
3 Humongous Health-Care Stocks This Week: Infinity Pharmaceuticals Inc. (INFI)
There's power in positive thinking. The late author Norman Vincent Peale made plenty of money off that philosophy.
